Assenagon Asset Management S.A. Acquires 52,394 Shares of Stoke Therapeutics, Inc. $STOK
Published . Updated .
Assenagon Asset Management S.A. Acquires 52,394 Shares of Stoke Therapeutics, Inc. $STOK MarketBeat
Directly affected
- STOK Stoke Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Assenagon Asset Management S.A. Acquires 52,394 Shares of Stoke Therapeutics, Inc. $STOK MarketBeat
Source: MarketBeat
The price since 18 Oct 2026: Stoke Therapeutics (STOK) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.63% | final price |
| GLD | the next day | -0.98% | still updating |
| GLD | three days earlier | -1.59% | final price |
| GLD | five days earlier | +0.03% | final price |
| QQQ | that day | +1.20% | final price |
| QQQ | the next day | +0.87% | still updating |
| QQQ | three days earlier | +2.70% | final price |
| QQQ | five days earlier | +5.10% | final price |
| SPY | that day | +0.43% | final price |
| SPY | the next day | +0.61% | still updating |
| SPY | three days earlier | +0.83% | final price |
| SPY | five days earlier | +1.93% | final price |
| Stoke Therapeutics (STOK) | that day | +2.64% | final price |
| Stoke Therapeutics (STOK) | the next day | +5.37% | still updating |
| Stoke Therapeutics (STOK) | three days earlier | -3.80% | final price |
| Stoke Therapeutics (STOK) | five days earlier | -0.27% | final price |
| TLT | that day | -0.72% | final price |
| TLT | the next day | +0.10% | still updating |
| TLT | three days earlier | -1.44% | final price |
| TLT | five days earlier | -2.51% | final price |
Who gains and who loses around Stoke Therapeutics (STOK)
Companies mentioned with this story
- STOK Stoke Therapeutics
In “Assenagon Asset Management S.A. Acquires 52,394 Shares of Stoke Therapeutics, Inc. $STOK,” Stoke Therapeutics (STOK) is linked, with no stored direction, high confidence. Reason on file: The source item explicitly associated this symbol with the reported development
Stoke Therapeutics (STOK)
Stoke Therapeutics (STOK) is the company in “Assenagon Asset Management S.A. Acquires 52,394 Shares of Stoke Therapeutics, Inc. $STOK,” the 18 Oct 2026 this story story.
The link for Stoke Therapeutics (STOK) is this: The source item explicitly associated this symbol with the reported development
Dates in the story, and the Stoke Therapeutics (STOK) price range
STOK traded between 24.13 and 29.68 across 13 sessions. The latest close on file is 24.84.
What the saved facts support for Stoke Therapeutics (STOK)
44 out of 100Price not final
“Assenagon Asset Management S.A. Acquires 52,394 Shares of Stoke Therapeutics, Inc. $STOK” scores 44 out of 100. The score uses 1 sources, a +4.76% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.